Powerful insights to help personalize treatment

This test is designed to help identify appropriate targeted therapies and clinical trials to facilitate first-line treatment selection or later-line care decisions. The Solid Tumor Panel tests for clinically significant mutations in solid tumor cancers, including

12 genes found in 19 guidelines for solid tumor genetic testing 117 genes included in 800+ clinical trials worldwide 9 genes associated with 36 targeted therapies approved by the FDA